Back to feed
RVMDRevolution Medicines, Inc.
CIK 0001628171 · last filing 2d ago · 6 insider transactions
Buy volume
$371.2K
2 buy transactions
Sell volume
$3.37M
4 sell transactions
Net flow
-$3.00M
Net selling
Total flow
$3.74M
6 priced transactions
Disclosure radarcross-source convergence
Divergent2/5 sources
0/100
Recent disclosures · timeline
- Form 42d ago
Chief Financial Officer · sold $3.00M
- Form 1444d ago
Proposed sale of 20,000 sh ($3.39M) · discretionary
Price · RVMD
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
RVMD insider flow· last 30 days
Buys Sellsnet -$3.00M
Proposed sales · Form 144
selling intent · live SEC data1 notice$3.39M proposed to sell0/1 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 4d ago | JACK ANDERS Officer | 20,000 | $3.39M | Jun 24, 2026 | Exercise of Stock Options | Discretionary |
Recent insider transactions
| Filed | Insider | Transaction | Shares | Price | Value | Signal | Flags | |
|---|---|---|---|---|---|---|---|---|
2d ago Jun 24, 2026 | Anders Jack Chief Financial Officer | Buy · M | 20,000 | $0.00 | $0 | Neutral-4 | 10b5-1Deriv | |
2d ago Jun 24, 2026 | Anders Jack Chief Financial Officer | Sell · S | 5,651 | $169.24 | $956.4K | Neutral-4 | 10b5-1 | |
2d ago Jun 24, 2026 | Anders Jack Chief Financial Officer | Sell · S | 300 | $170.32 | $51.1K | Neutral-4 | 10b5-1 | |
2d ago Jun 24, 2026 | Anders Jack Chief Financial Officer | Buy · M | 20,000 | $18.56 | $371.2K | Neutral-4 | 10b5-1 | |
2d ago Jun 24, 2026 | Anders Jack Chief Financial Officer | Sell · S | 4,553 | $167.35 | $761.9K | Neutral-4 | 10b5-1 | |
2d ago Jun 24, 2026 | Anders Jack Chief Financial Officer | Sell · S | 9,496 | $168.20 | $1.60M | Neutral-4 | 10b5-1 |